Histiocytic necrotising lymphadenitis is the pathognomonic histological appearance of lymph nodes in Kikuchi's disease, a condition characterised by a brief systemic illness and lymphadenopathy.
Histiocytic necrotising lymphadenitis was first described in Japan in 1972,1 2 and is now increasingly recognised in Europe and the USA.3 Its diagnosis is based on a characteristic histological appearance of 'lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis'.3 Recent case reports4" and an editorial9 have tended to reinforce the association ofhistiocytic necrotising lymphadenitis with a brief illness in previously healthy women which has a benign, uncomplicated prognosis. So confidently has this pathological lymphadenopathy been assumed to represent a discrete clinical entity that it has received an eponymous name, 'Kikuchi's disease', after one of the first Japanese pathologists to describe it. Although it is important that doctors recognise the characteristic, self limiting presentations of histiocytic necrotising lymphadenitis with systemic illness and lymphadenopathy, they need also to appreciate that some patients with the same pathological diagnosis go on to develop progressive and severe disorders. One review has briefly described the development of systemic lupus erythematosus (SLE) after an initial diagnosis of histiocytic necrotising lymphadenitis. Generalised lymphadenopathy of the size seen in this patient is rare as a presenting feature of SLE. Nodal size is usually not more than three to four centimetres." Dubois found cervical lymphadenopathy to be the presenting feature of SLE in 1-7% of patients, and generalised adenopathy in 0-5-2 0%." Of established cases 50% had generalised lymphadenopathy. The histology of nodes in SLE is variable'2 and can overlap those changes seen in histiocytic necrotising lymphadenitis.3 B lymphocyte activation was assessed in our patient by assaying the number of peripheral blood cells secreting IgG, IgA, and IgM, at various times during his illness (see table) . This paralleled other parameters of disease activity. Increased numbers of antibody secreting cells are a characteristic feature in active SLE'3 but findings in histiocytic necrotising lymphadenitis have not previously been reported.
Despite his overall improvement, mild dyspnoea and haemoptysis persisted. Fleeting pulmonary infiltrates and increased Kco values suggested pulmonary haemorrhage, which was confirmed. Reports of alveolar haemorrhage in SLE describe acute, life threatening events usually in the context of glomerulonephritis and hypocomplementaemia, unlike the relatively asymptomatic nature of this problem. 1'16 High doses of steroids and immunosuppressive drugs were given empirically because of the perceived threat to his lungs. There is, however, a lack of prognostic and management data about this aspect of SLE.
The association of SLE with histiocytic necrotising lymphadenitis has been suggested in one previous review, but the 
